REGULATION OF MICROBIOME-BASED COSMETIC PRODUCTS

1. INTRODUCTION

Microbiome-based cosmetic products are skincare, haircare, and personal-care formulations designed to influence the microorganisms naturally present on human skin. These products may contain probiotics, prebiotics, postbiotics, microbial extracts, or other ingredients intended to maintain or support the skin microbiome.

Examples include probiotic skincare creams, microbiome-balancing facial cleansers, protective lotions, scalp microbiome treatments, and products designed to support the skin's natural microbial ecosystem.

Their regulation raises important questions concerning product safety, microbial contamination, ingredient quality, scientific substantiation, consumer protection, advertising claims, and manufacturing standards.

In India, microbiome-based cosmetics are principally regulated under the Drugs and Cosmetics Act, 1940, the Cosmetics Rules, 2020, and the Consumer Protection Act, 2019. Depending on their composition, intended use, and therapeutic claims, certain products may also fall under additional drug, biological-product, or other regulatory requirements.

2. LEGAL FRAMEWORK GOVERNING MICROBIOME-BASED COSMETICS

A. DRUGS AND COSMETICS ACT, 1940

Section 3(aaa) defines cosmetics as articles intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance.

Section 3(a) defines drugs, which is relevant where a product's intended purpose and claims bring it within the statutory drug definition.

Section 18 prohibits specified activities involving cosmetics that do not comply with statutory requirements.

Section 27 provides penalties for specified offences involving drugs; cosmetic violations must be assessed under the applicable cosmetic provisions rather than automatically applying drug penalties.

B. COSMETICS RULES, 2020

The Cosmetics Rules, 2020 establish requirements concerning cosmetic manufacturing, importation, licensing, quality control, labelling, and compliance.

Microbiome-based cosmetic manufacturers must ensure that their formulations comply with applicable ingredient restrictions, manufacturing requirements, and prescribed quality standards.

Products containing viable microorganisms require particular attention to identity, purity, stability, microbial quality, and contamination control.

C. CONSUMER PROTECTION ACT, 2019

The Consumer Protection Act regulates misleading advertisements, unfair trade practices, and defective products.

Manufacturers must not make unsupported claims that a microbiome-based cosmetic cures eczema, eliminates infections, treats medical conditions, or permanently restores microbial balance.

3. REGULATORY AUTHORITIES AND RESPONSIBILITIES

Central Drugs Standard Control Organisation (CDSCO): Oversees relevant central regulatory functions concerning cosmetics, including import-related regulation.

State Licensing Authorities: Exercise applicable licensing and enforcement functions concerning cosmetic manufacturing.

Bureau of Indian Standards (BIS): Develops relevant product and quality standards.

Central Consumer Protection Authority (CCPA): Addresses misleading advertisements and unfair trade practices.

Food Safety and Standards Authority of India (FSSAI): May become relevant where a product is legally classified as food or a nutraceutical rather than a cosmetic.

4. PRINCIPAL SAFETY AND COMPLIANCE REQUIREMENTS

A. MICROBIAL IDENTITY AND PURITY

Manufacturers should establish the identity, purity, and quality of microorganisms used in formulations. Contamination by unintended microorganisms must be controlled.

B. PRODUCT SAFETY ASSESSMENT

Products should undergo appropriate safety assessments, including evaluation of irritation, sensitisation, stability, and microbiological quality.

C. MANUFACTURING QUALITY CONTROL

Manufacturers must maintain suitable hygiene, quality-control procedures, batch documentation, and manufacturing practices under applicable cosmetic requirements.

D. LABELLING AND DISCLOSURE

Labels must comply with applicable statutory requirements. Relevant ingredient information, manufacturer details, batch identification, and other prescribed particulars must be provided.

E. SCIENTIFIC SUBSTANTIATION

Claims concerning skin microbiome improvement, microbial diversity, skin-barrier support, or protective effects should be supported by reliable scientific evidence appropriate to the claim.

5. SPECIAL REGULATORY ISSUES

A. PROBIOTIC AND POSTBIOTIC INGREDIENTS

Products containing live microorganisms require particular attention to microbial identity, product stability, contamination, and consumer safety. Non-living microbial derivatives and prebiotic ingredients also require appropriate quality and safety evaluation.

B. PRODUCT CLASSIFICATION

A cosmetic marketed for cleansing, beautifying, or improving appearance may fall under cosmetic regulation. However, claims to diagnose, treat, mitigate, or prevent diseases may bring the product within the definition of a drug under Section 3(b) of the Drugs and Cosmetics Act, 1940.

C. FALSE HEALTH CLAIMS

Claims that a cosmetic eliminates harmful bacteria, cures acne, treats dermatitis, or prevents skin infections must not be made without the appropriate legal authorization and scientific basis.

6. RELEVANT JUDICIAL DECISIONS

The following six decisions establish important direct or analogous principles for microbiome-based cosmetic regulation.

1. Tata Press Ltd. v. Mahanagar Telephone Nigam Ltd. (1995)

Authority: Directly relevant to advertising regulation.

The Supreme Court recognized commercial advertising as protected speech under Article 19(1)(a), while distinguishing legitimate commercial information from misleading representations. This principle applies to microbiome cosmetics making claims about skin health, microbial balance, and product effectiveness.

2. Dabur India Ltd. v. Colortek Meghalaya Pvt. Ltd. (2010)

Authority: Directly relevant to cosmetic advertising.

The Delhi High Court established that advertisements must not be false, misleading, unfair, or deceptive. Manufacturers may promote their products, but cannot make unsupported factual claims or unfairly disparage competing products.

3. Reckitt Benckiser (India) Pvt. Ltd. v. Hindustan Unilever Ltd. (2022)

Authority: Directly relevant to comparative product claims.

The Delhi High Court examined comparative advertising and distinguished permissible promotional exaggeration from misleading factual representations. This principle is relevant when microbiome cosmetic manufacturers compare their formulations with conventional skincare products.

4. Dabur India Ltd. v. The Advertising Standards Council of India (2023)

Authority: Directly relevant to scientific substantiation.

The Delhi High Court considered scientific substantiation of advertising claims and the role of the Advertising Standards Council of India. The decision highlights that health-related product claims cannot automatically be justified as advertising exaggeration when their scientific foundation is questioned.

5. Marico Ltd. v. Adani Wilmar Ltd. (2013)

Authority: Analogous consumer-protection and advertising authority.

The Delhi High Court examined the boundaries of permissible advertising exaggeration and comparative claims. The decision supports the requirement that factual assertions concerning product quality and benefits should have a reasonable basis.

6. National Seeds Corporation Ltd. v. M. Madhusudhan Reddy (2012)

Authority: Analogous product-defect and consumer liability.

The Supreme Court considered consumer remedies concerning defective agricultural seeds. Although the case did not concern cosmetics, its principles concerning defective products, consumer protection, and available remedies are relevant by analogy to defective microbiome-based cosmetic products.

7. PRACTICAL COMPLIANCE REQUIREMENTS

Manufacturers and distributors should implement the following measures:

Obtain the appropriate manufacturing licence from the competent State Licensing Authority.

Obtain CDSCO registration before importing cosmetics into India.

Maintain documentation identifying microbial and non-microbial ingredients.

Establish suitable microbiological quality and contamination-control procedures.

Conduct appropriate product stability and safety assessments.

Maintain batch manufacturing and quality-control records.

Ensure compliance with applicable ingredient restrictions and labelling standards.

Substantiate microbiome-related advertising claims through reliable scientific evidence.

Establish complaint-handling and product-recall procedures.

Review product classification whenever therapeutic claims or intended uses change.

8. LEGAL CHALLENGES AND REGULATORY GAPS

The principal challenges include the absence of a dedicated statutory category specifically addressing microbiome-based cosmetics, difficulties in establishing long-term microbial stability, inconsistent scientific evidence concerning microbiome benefits, and uncertainty surrounding the classification of products containing viable microorganisms.

Regulators must also address consumer protection, misleading health claims, ingredient traceability, and potential adverse reactions.

9. CONCLUSION

The regulation of microbiome-based cosmetic products requires a combination of cosmetic safety standards, microbial quality control, scientific substantiation, manufacturing supervision, and consumer protection.

In India, the Drugs and Cosmetics Act, 1940, Cosmetics Rules, 2020, and Consumer Protection Act, 2019 provide the principal legal framework. Judicial decisions including Tata Press, Dabur India v. Colortek, Reckitt Benckiser, and Dabur India v. ASCI establish important principles concerning advertising accuracy, scientific substantiation, and consumer protection.

A comprehensive regulatory approach should ensure that microbiome-based cosmetics are safe, properly classified, accurately labelled, scientifically supported, and manufactured under appropriate quality standards. This will encourage responsible cosmetic innovation while protecting consumer health and confidence.

LEGAL REFERENCE NOTE: There is no separate comprehensive Indian statute exclusively governing microbiome-based cosmetics. The cases discussed above are direct authorities on relevant cosmetic advertising principles or analogous authorities on consumer protection and defective products; they should not be represented as judgments specifically deciding the legality of microbiome-based cosmetics.